Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and fluconazole

carbapenems has been researched along with fluconazole in 5 studies

Compound Research Comparison

Studies
(carbapenems)		Trials
(carbapenems)		Recent Studies (post-2010)
(carbapenems)		Studies
(fluconazole)		Trials
(fluconazole)		Recent Studies (post-2010) (fluconazole)
7,3551475,2779,3437213,664

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)fluconazole (IC50)
Lanosterol 14-alpha demethylaseCandida albicans SC53140.1296
Cytochrome P450 2C9 Homo sapiens (human)9.21
Sterol 14-alpha demethylaseTrypanosoma cruzi strain CL Brener0.88

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Ben-Ami, R; Bishara, J; Block, C; Chazan, B; Chowers, M; Dan, M; Giladi, M; Kassis, I; Keller, N; Kontoyiannis, DP; Krieger, M; Olshtain-Pops, K; Oren, I; Potasman, I; Shalit, I; Weber, G; Weinberger, M; Wiener-Well, Y; Zimhony, O1
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S1
Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC1
Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N1
Abdel-Aziz, MM; Abuelizz, HA; Al-Salahi, R; Bakhiet, A; Ezzeldin, E; Marzouk, M; Rashid, H1

Other Studies

5 other study(ies) available for carbapenems and fluconazole

ArticleYear
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida glabrata; Candidemia; Candidiasis; Carbapenems; Clindamycin; Coinfection; Colistin; Drug Resistance, Fungal; Female; Fluconazole; Humans; Israel; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination

2012
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
    Infection control and hospital epidemiology, 2015, Volume: 36, Issue:7

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts

2015
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
    Critical care (London, England), 2015, Dec-15, Volume: 19

    Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin

2015
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
    Clinical biochemistry, 2021, Volume: 90

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole

2021
In silico study and biological screening of benzoquinazolines as potential antimicrobial agents against methicillin-resistant Staphylococcus aureus, carbapenem-resistant Klebsiella pneumoniae, and fluconazole-resistant Candida albicans.
    Microbial pathogenesis, 2021, Volume: 160

    Topics: Anti-Bacterial Agents; Candida albicans; Carbapenems; Computer Simulation; Drug Resistance, Bacterial; Fluconazole; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests

2021